Answers are grounded in this paper and cite their sources.
α-Mangostin (αM) is a natural xanthone with broad pharmacological activity; however, its therapeutic use is limited by poor aqueous solubility and low bioavailability. Amorphous Solid Dispersion (ASD) is a practical strategy for improving poorly soluble drugs; however, polymer selection remains a critical step that should be supported by molecular-level evidence of drug–polymer compatibility. In this study, 500 ns Molecular Dynamics (MD) simulations followed by Molecular Mechanics/Poisson–Boltzmann Surface Area (MM/PBSA) analysis were used to compare the association of αM with Soluplus® and Kollidon® VA64 at drug-to-polymer ratios of 1:1, 1:3, 1:5, and 1:7. All systems reached relatively stable configurations, but the two polymers stabilized αM differently. Soluplus® 1:3 produced the most stable global structure based on RMSD, whereas Kollidon® VA64 showed its best stability at 1:7. Soluplus® displayed a stronger interaction network: at 1:7, it generated 1150 hydrogen-bond pairs with 231.17% cumulative occupancy, compared with 900 pairs and 96.69% for Kollidon® VA64. Binding energies ranged from −126.24 to −484.09 kJ/mol for Soluplus® and from −71.58 to −382.42 kJ/mol for Kollidon® VA64, mainly driven by van der Waals contacts. These results indicate that Soluplus® provides a more favorable molecular environment for further αM ASD development.
No takes yet. Share an insight, caveat, or question.
Firmansyah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: